Treating high blood pressure and other so-called vascular risk factors in people who have mild cognitive impairment may reduce their risk of progressing to Alzheimer’s disease, according to a new study.
Continue reading …An experimental epilepsy drug may help reduce seizures in as many as one-third of people with epilepsy who either don’t tolerate or don’t respond adequately to existing seizure drugs.
Continue reading …Men with fibromyalgia talk with WebMD about their fibromyalgia symptoms, diagnosis, and how fibromyalgia affects their lives.
Continue reading …Concerned about the plastic chemical bisphenol A? Read what government and industry experts say.
Continue reading …The FDA has approved a test to diagnose people with dengue fever, a sometimes deadly viral illness spread by mosquitoes.
Continue reading …The experimental oral multiple sclerosis (MS) drug laquinimod delayed disease progression, reduced relapse rates, and was safe and well tolerated by patients in a two-year study.
Continue reading …Delaying doses of a vaccine that protects against cervical cancer doesn’t appear to make it any less safe or effective, a new study shows.
Continue reading …The U.S. government has introduced a new approach to fight barriers to good health care faced by many minorities.
Continue reading …People with Parkinson’s disease who walk on a treadmill at a comfortable, low-intensity speed may be able to improve their gait and mobility, new research indicates.
Continue reading …